Literature DB >> 25054566

Is previous respiratory disease a risk factor for lung cancer?

Rachel Denholm1, Joachim Schüz, Kurt Straif, Isabelle Stücker, Karl-Heinz Jöckel, Darren R Brenner, Sara De Matteis, Paolo Boffetta, Florence Guida, Irene Brüske, Heinz-Erich Wichmann, Maria Teresa Landi, Neil Caporaso, Jack Siemiatycki, Wolfgang Ahrens, Hermann Pohlabeln, David Zaridze, John K Field, John McLaughlin, Paul Demers, Neonila Szeszenia-Dabrowska, Jolanta Lissowska, Peter Rudnai, Eleonora Fabianova, Rodica Stanescu Dumitru, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Benjamin Kendzia, Susan Peters, Thomas Behrens, Roel Vermeulen, Thomas Brüning, Hans Kromhout, Ann C Olsson.   

Abstract

RATIONALE: Previous respiratory diseases have been associated with increased risk of lung cancer. Respiratory conditions often co-occur and few studies have investigated multiple conditions simultaneously.
OBJECTIVES: Investigate lung cancer risk associated with chronic bronchitis, emphysema, tuberculosis, pneumonia, and asthma.
METHODS: The SYNERGY project pooled information on previous respiratory diseases from 12,739 case subjects and 14,945 control subjects from 7 case-control studies conducted in Europe and Canada. Multivariate logistic regression models were used to investigate the relationship between individual diseases adjusting for co-occurring conditions, and patterns of respiratory disease diagnoses and lung cancer. Analyses were stratified by sex, and adjusted for age, center, ever-employed in a high-risk occupation, education, smoking status, cigarette pack-years, and time since quitting smoking.
MEASUREMENTS AND MAIN RESULTS: Chronic bronchitis and emphysema were positively associated with lung cancer, after accounting for other respiratory diseases and smoking (e.g., in men: odds ratio [OR], 1.33; 95% confidence interval [CI], 1.20-1.48 and OR, 1.50; 95% CI, 1.21-1.87, respectively). A positive relationship was observed between lung cancer and pneumonia diagnosed 2 years or less before lung cancer (OR, 3.31; 95% CI, 2.33-4.70 for men), but not longer. Co-occurrence of chronic bronchitis and emphysema and/or pneumonia had a stronger positive association with lung cancer than chronic bronchitis "only." Asthma had an inverse association with lung cancer, the association being stronger with an asthma diagnosis 5 years or more before lung cancer compared with shorter.
CONCLUSIONS: Findings from this large international case-control consortium indicate that after accounting for co-occurring respiratory diseases, chronic bronchitis and emphysema continue to have a positive association with lung cancer.

Entities:  

Keywords:  case–control study; data pooling; epidemiologic study; lung neoplasm; pulmonary disease

Mesh:

Year:  2014        PMID: 25054566      PMCID: PMC4214084          DOI: 10.1164/rccm.201402-0338OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

Authors:  Alicia M Fry; David K Shay; Robert C Holman; Aaron T Curns; Larry J Anderson
Journal:  JAMA       Date:  2005-12-07       Impact factor: 56.272

2.  Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses.

Authors:  R Graham Barr; Julie Herbstman; Frank E Speizer; Carlos A Camargo
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

3.  Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers.

Authors:  Michelle C Turner; Yue Chen; Daniel Krewski; Eugenia E Calle; Michael J Thun
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

Review 4.  A cytokine-mediated link between innate immunity, inflammation, and cancer.

Authors:  Wan-Wan Lin; Michael Karin
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

5.  Previous lung disease and risk of lung cancer among men and women nonsmokers.

Authors:  S T Mayne; J Buenconsejo; D T Janerich
Journal:  Am J Epidemiol       Date:  1999-01-01       Impact factor: 4.897

6.  Agreement between obstructive airways disease diagnoses from self-report questionnaires and medical records.

Authors:  Jessica Weakley; Mayris P Webber; Fen Ye; Rachel Zeig-Owens; Hillel W Cohen; Charles B Hall; Kerry Kelly; David J Prezant
Journal:  Prev Med       Date:  2013-04-16       Impact factor: 4.018

7.  A standard tool for the analysis of occupational lung cancer in epidemiologic studies.

Authors:  W Ahrens; F Merletti
Journal:  Int J Occup Environ Health       Date:  1998 Oct-Dec

8.  Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability.

Authors:  Lisa Iversen; Philip C Hannaford; David J Godden; David Price
Journal:  Prim Care Respir J       Date:  2007-06

9.  Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.

Authors:  A H Wu; E T Fontham; P Reynolds; R S Greenberg; P Buffler; J Liff; P Boyd; B E Henderson; P Correa
Journal:  Am J Epidemiol       Date:  1995-06-01       Impact factor: 4.897

10.  The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population.

Authors:  Roberto de Marco; Giancarlo Pesce; Alessandro Marcon; Simone Accordini; Leonardo Antonicelli; Massimiliano Bugiani; Lucio Casali; Marcello Ferrari; Gabriele Nicolini; Maria Grazia Panico; Pietro Pirina; Maria Elisabetta Zanolin; Isa Cerveri; Giuseppe Verlato
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more
  41 in total

Review 1.  Atopy and Specific Cancer Sites: a Review of Epidemiological Studies.

Authors:  Yubao Cui; Andrew W Hill
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 2.  Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now?

Authors:  Hae-Seong Nam; Evgeny Izumchenko; Santanu Dasgupta; Mohammad O Hoque
Journal:  Biomark Med       Date:  2017-06-09       Impact factor: 2.851

3.  The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.

Authors:  Amanda B Muir; Kelly A Whelan; Michael K Dougherty; Bailey Aaron; Brianna Navarre; Seema S Aceves; Evan S Dellon; Elizabeth T Jensen
Journal:  Clin Exp Allergy       Date:  2019-12-20       Impact factor: 5.018

4.  Allergies and Asthma in Relation to Cancer Risk.

Authors:  Elizabeth D Kantor; Meier Hsu; Mengmeng Du; Lisa B Signorello
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-05       Impact factor: 4.254

5.  Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer.

Authors:  Jiunn-Liang Tan; Zheng-Xin Yong; Chong-Kin Liam
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

6.  Risk of Malignant Cancers in Inflammatory Bowel Disease.

Authors:  Simone Y Loo; Maria Vutcovici; Alain Bitton; Peter L Lakatos; Laurent Azoulay; Samy Suissa; Paul Brassard
Journal:  J Crohns Colitis       Date:  2019-09-27       Impact factor: 9.071

Review 7.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

Review 8.  Update in Lung Cancer 2014.

Authors:  Avrum Spira; Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

9.  Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race.

Authors:  Lisa D Gardner; Christopher A Loffredo PhD; Patricia Langenberg; Diane Marie St George; Janaki Deepak; Curtis C Harris; Sania Amr
Journal:  Ann Epidemiol       Date:  2018-05-07       Impact factor: 3.797

10.  Histopathological Type of Lung Cancer and Underlying Driver Mutations in Patients with Chronic Obstructive Pulmonary Disease (COPD) versus Patients with Asthma and COPD Overlap: A Single-Center Retrospective Study.

Authors:  Tamami Sakai; Johsuke Hara; Kenta Yamamura; Miki Abo; Akihito Okazaki; Noriyuki Ohkura; Kazuo Kasahara
Journal:  Turk Thorac J       Date:  2020-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.